Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-003726
Filing Date
2021-03-30
Accepted
2021-03-30 17:01:19
Documents
106
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K osmt-20201231x10k.htm 10-K 2803891
2 EX-4.2 osmt-20201231ex42947309e.htm EX-4.2 35883
3 EX-4.4 osmt-20201231ex44a3bea72.htm EX-4.4 135383
4 EX-10.25 osmt-20201231ex102511c8a.htm EX-10.25 2071063
5 EX-21.1 osmt-20201231ex211ae34ba.htm EX-21.1 11863
6 EX-23.1 osmt-20201231ex23112d1d2.htm EX-23.1 5500
7 EX-31.1 osmt-20201231ex3113fd9c7.htm EX-31.1 9956
8 EX-31.2 osmt-20201231ex312bc27dd.htm EX-31.2 9525
9 EX-32.1 osmt-20201231ex321953c24.htm EX-32.1 8087
10 EX-32.2 osmt-20201231ex32258f297.htm EX-32.2 8080
11 GRAPHIC osmt-20201231x10k002.jpg GRAPHIC 12559
12 GRAPHIC osmt-20201231x10k003.jpg GRAPHIC 21850
13 GRAPHIC osmt-20201231x10k004.jpg GRAPHIC 27848
14 GRAPHIC osmt-20201231x10k005.jpg GRAPHIC 27761
  Complete submission text file 0001558370-21-003726.txt   15742792

Data Files

Seq Description Document Type Size
15 EX-101.INS osmt-20201231.xml EX-101.INS 3475029
16 EX-101.SCH osmt-20201231.xsd EX-101.SCH 71914
17 EX-101.CAL osmt-20201231_cal.xml EX-101.CAL 98532
18 EX-101.DEF osmt-20201231_def.xml EX-101.DEF 366196
19 EX-101.LAB osmt-20201231_lab.xml EX-101.LAB 730508
20 EX-101.PRE osmt-20201231_pre.xml EX-101.PRE 599200
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 001-38709 | Film No.: 21787385
SIC: 2834 Pharmaceutical Preparations